{"id":134411,"date":"2024-09-25T14:07:36","date_gmt":"2024-09-25T08:37:36","guid":{"rendered":"https:\/\/tradebrains.in\/features\/?p=134411"},"modified":"2024-09-25T14:26:23","modified_gmt":"2024-09-25T08:56:23","slug":"pharma-stock-to-buy-now-for-an-upside-of-15-are-you-holding-it","status":"publish","type":"post","link":"https:\/\/tradebrains.in\/features\/pharma-stock-to-buy-now-for-an-upside-of-15-are-you-holding-it\/","title":{"rendered":"Pharma stock to buy now for an upside of 20%; Are you holding it?"},"content":{"rendered":"<div class=\"trade-content_2\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-151244563\"><p><a href=\"https:\/\/tradebrains.in\/get\/telegram\/\"><img decoding=\"async\" class=\"alignnone wp-image-101992\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/telegram-channel-300x119.png\" alt=\"\" width=\"148\" height=\"59\" \/><\/a> <a href=\"https:\/\/news.google.com\/publications\/CAAqBwgKMN3Epgswxc--Aw?hl=en-IN&amp;gl=IN&amp;ceid=IN%3Aen\"><img decoding=\"async\" class=\"alignnone wp-image-123430\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png\" alt=\"follow-on-google-news\" width=\"222\" height=\"61\" srcset=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png 300w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-150x41.png 150w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news.png 468w\" sizes=\"(max-width: 222px) 100vw, 222px\" \/><\/a><\/p>\n<\/div><p>Mid-cap pharma stock rose above 8% after a well-known brokerage gave a Buy recommendation on the company\u2019s stock with an upside of around 20 percent.&nbsp;<\/p><div class=\"trade-content_7\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-3537963900\"><!-- Composite Start --> \r\n <div id=\"M923760ScriptRootC1549812\"> \r\n <\/div> \r\n <script src=\"https:\/\/jsc.mgid.com\/t\/r\/tradebrains.in.1549812.js\" async> \r\n <\/script> \r\n <!-- Composite End --><\/div><h2 class=\"wp-block-heading\"><strong>Share price variations:&nbsp;<\/strong><\/h2><p>With a market capitalization of Rs. 28,728 crores, the shares of <strong>Piramal Pharma Limited <\/strong>opened the trading session at Rs. 229.00 up 5.65 % to the previous day&#8217;s close of Rs. 217.67 and went up to make an intraday high of Rs. 235.42 up 8.15% from the previous close.&nbsp;<\/p><p>At 1:57 pm the stock was trading at Rs. 226.50 about 4.10% above previous day&#8217;s close<em>. <\/em>The stock has delivered impressive returns for its investors, rising over 91% in just six months.&nbsp;<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Reason for Rise:&nbsp;<\/strong><\/h2><p>The recent movement in <strong>Piramal Pharma\u2019s <\/strong>stock price was triggered after Jefferies, one of the well-known Investment Banks across the globe, has set the target price to Rs 260 indicating a potential upside of 20% from the initial target price, however the stock has moved by 8% in today&#8217;s trading session. Now the upside potential is 15% from current price.&nbsp;<\/p><div class=\"trade-content_5\" id=\"trade-4060261670\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_2_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"7925020301\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p><strong>Also Read: <a href=\"https:\/\/tradebrains.in\/features\/smallcap-stock-surges-9-after-announcing-record-date-for-15-stock-split\/\" target=\"_blank\" rel=\"noreferrer noopener\">Smallcap stock jumps 9% after announcing record date for 1:5 stock split<\/a>\u00a0<\/strong><\/p><\/blockquote><p>The recommendation is based on the company&#8217;s goal of achieving USD 2 billion in revenue by the financial year 2030, with the Contract Development and Manufacturing Organization segment identified as a key growth driver.The also aims to attain a 25% EBITDA margins by 2030.&nbsp;<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Financial Performance:&nbsp;<\/strong><\/h2><p>For Q1FY25 the company reduced its net loss to Rs. 88.64 crores compared to Rs. 98.58 crores in Q1FY24, while revenue from operations marked an increase by 11.56 % to Rs. 1,951.14 crores from Rs. 1,748.85 crores in comparison to the same period.&nbsp;<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Recent Developments:&nbsp;<\/strong><\/h2><p>Recently, Piramal Pharma acquired a 15.76% stake in Clean Max Aero Private Limited, a company that supplies renewable energy. This investment allows Piramal Pharma to become a \u2018Captive User,\u2019 enabling the procurement of renewable energy for its operations.<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>About the company&nbsp;<\/strong><\/h2><p>Piramal Pharma Limited is a part of the Piramal Group, a global business conglomerate. The company offers a portfolio of differentiated pharma products and services through its 17 global development and manufacturing facilities and a global distribution network in over 100 countries.&nbsp;<\/p><p>The company operates through 3 major segments,a Contract development and manufacturing organisations, a Complex hospital generics business and the India Consumer Healthcare business, selling over-the- counter products.<\/p><blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p><strong>Also Read: <a href=\"https:\/\/tradebrains.in\/features\/smallcap-stock-hits-20-lower-circuit-after-14-stake-worth-900-cr-changed-hands\/\" target=\"_blank\" rel=\"noreferrer noopener\">Smallcap stock hits 20% lower circuit after 14% stake worth \u20b9 900 Cr changed hands<\/a><\/strong><\/p><\/blockquote><blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p><strong>Written By<\/strong>: <strong>Joseph Pv<\/strong><\/p><\/blockquote><h4 class=\"wp-block-heading has-medium-font-size\" id=\"h-disclaimer\"><strong>Disclaimer<\/strong><\/h4><div class=\"wp-block-image\"><figure class=\"aligncenter size-medium\"><img decoding=\"async\" width=\"300\" height=\"300\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/02\/warning-disclaimer-300x300.png\" alt=\"\" class=\"wp-image-26306\"\/><\/figure><\/div><p><strong>The views and investment tips expressed by investment experts\/broking houses\/rating agencies on <a href=\"http:\/\/tradebrains.in\/\">tradebrains.in<\/a> are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing<\/strong>.<\/p><div class=\"trade-content-10\" id=\"trade-2004168502\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_3_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"2969612066\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><div class=\"trade-after-content\" id=\"trade-582389301\"><div id=\"taboola-below-article-thumbnails\"><\/div>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({\r\n    mode: 'alternating-thumbnails-a',\r\n    container: 'taboola-below-article-thumbnails',\r\n    placement: 'Below Article Thumbnails',\r\n    target_type: 'mix'\r\n  });\r\n<\/script>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({flush: true});\r\n<\/script><\/div>","protected":false},"excerpt":{"rendered":"<p>Mid-cap pharma stock rose above 8% after a well-known brokerage gave a Buy recommendation on the company\u2019s stock with an upside of around 20 percent.&nbsp; Share price variations:&nbsp; With a market capitalization of Rs. 28,728 crores, the shares of Piramal Pharma Limited opened the trading session at Rs. 229.00 up 5.65 % to the previous [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":111747,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[31,1789],"tags":[17273,5027,15247,14471,22875,948,936,2597],"class_list":["post-134411","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-trending-news","tag-pharma-stock-to-buy-now","tag-piramal-pharma","tag-piramal-pharma-latest-news","tag-piramal-pharma-share-price","tag-piramal-pharma-target","tag-stock-market","tag-stock-market-news","tag-stocks-to-watch"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.5 (Yoast SEO v25.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Pharma stock to buy now for an upside of 20%; Are you holding it? - Trade Brains Features<\/title>\n<meta name=\"description\" content=\"Mid-cap pharma stock rose above 8% after a well-known brokerage gave a Buy recommendation on the company\u2019s stock with an upside of around 20 percent.\u00a0\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tradebrains.in\/features\/pharma-stock-to-buy-now-for-an-upside-of-15-are-you-holding-it\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharma stock to buy now for an upside of 20%; Are you holding it?\" \/>\n<meta property=\"og:description\" content=\"Mid-cap pharma stock rose above 8% after a well-known brokerage gave a Buy recommendation on the company\u2019s stock with an upside of around 20 percent.\u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tradebrains.in\/features\/pharma-stock-to-buy-now-for-an-upside-of-15-are-you-holding-it\/\" \/>\n<meta property=\"og:site_name\" content=\"Trade Brains Features\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/TradeBrainsOfficial\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-09-25T08:37:36+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-09-25T08:56:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"854\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Trade Brains\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:site\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Trade Brains\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-to-buy-now-for-an-upside-of-15-are-you-holding-it\/\",\"url\":\"https:\/\/tradebrains.in\/features\/pharma-stock-to-buy-now-for-an-upside-of-15-are-you-holding-it\/\",\"name\":\"Pharma stock to buy now for an upside of 20%; Are you holding it? - Trade Brains Features\",\"isPartOf\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-to-buy-now-for-an-upside-of-15-are-you-holding-it\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-to-buy-now-for-an-upside-of-15-are-you-holding-it\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg\",\"datePublished\":\"2024-09-25T08:37:36+00:00\",\"dateModified\":\"2024-09-25T08:56:23+00:00\",\"author\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\"},\"description\":\"Mid-cap pharma stock rose above 8% after a well-known brokerage gave a Buy recommendation on the company\u2019s stock with an upside of around 20 percent.\u00a0\",\"breadcrumb\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-to-buy-now-for-an-upside-of-15-are-you-holding-it\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/tradebrains.in\/features\/pharma-stock-to-buy-now-for-an-upside-of-15-are-you-holding-it\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-to-buy-now-for-an-upside-of-15-are-you-holding-it\/#primaryimage\",\"url\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg\",\"contentUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg\",\"width\":1280,\"height\":854},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-to-buy-now-for-an-upside-of-15-are-you-holding-it\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/tradebrains.in\/features\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharma stock to buy now for an upside of 20%; Are you holding it?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/tradebrains.in\/features\/#website\",\"url\":\"https:\/\/tradebrains.in\/features\/\",\"name\":\"Trade Brains\",\"description\":\"Stock Market NSE\/BSE Latest News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/tradebrains.in\/features\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\",\"name\":\"Trade Brains\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"caption\":\"Trade Brains\"},\"sameAs\":[\"http:\/\/tradebrains.in\/\"],\"url\":\"https:\/\/tradebrains.in\/features\/author\/trade-brains\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Pharma stock to buy now for an upside of 20%; Are you holding it? - Trade Brains Features","description":"Mid-cap pharma stock rose above 8% after a well-known brokerage gave a Buy recommendation on the company\u2019s stock with an upside of around 20 percent.\u00a0","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tradebrains.in\/features\/pharma-stock-to-buy-now-for-an-upside-of-15-are-you-holding-it\/","og_locale":"en_US","og_type":"article","og_title":"Pharma stock to buy now for an upside of 20%; Are you holding it?","og_description":"Mid-cap pharma stock rose above 8% after a well-known brokerage gave a Buy recommendation on the company\u2019s stock with an upside of around 20 percent.\u00a0","og_url":"https:\/\/tradebrains.in\/features\/pharma-stock-to-buy-now-for-an-upside-of-15-are-you-holding-it\/","og_site_name":"Trade Brains Features","article_publisher":"https:\/\/www.facebook.com\/TradeBrainsOfficial\/","article_published_time":"2024-09-25T08:37:36+00:00","article_modified_time":"2024-09-25T08:56:23+00:00","og_image":[{"width":1280,"height":854,"url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg","type":"image\/jpeg"}],"author":"Trade Brains","twitter_card":"summary_large_image","twitter_creator":"@TradeBrainsGrp","twitter_site":"@TradeBrainsGrp","twitter_misc":{"Written by":"Trade Brains","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-to-buy-now-for-an-upside-of-15-are-you-holding-it\/","url":"https:\/\/tradebrains.in\/features\/pharma-stock-to-buy-now-for-an-upside-of-15-are-you-holding-it\/","name":"Pharma stock to buy now for an upside of 20%; Are you holding it? - Trade Brains Features","isPartOf":{"@id":"https:\/\/tradebrains.in\/features\/#website"},"primaryImageOfPage":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-to-buy-now-for-an-upside-of-15-are-you-holding-it\/#primaryimage"},"image":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-to-buy-now-for-an-upside-of-15-are-you-holding-it\/#primaryimage"},"thumbnailUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg","datePublished":"2024-09-25T08:37:36+00:00","dateModified":"2024-09-25T08:56:23+00:00","author":{"@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666"},"description":"Mid-cap pharma stock rose above 8% after a well-known brokerage gave a Buy recommendation on the company\u2019s stock with an upside of around 20 percent.\u00a0","breadcrumb":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-to-buy-now-for-an-upside-of-15-are-you-holding-it\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tradebrains.in\/features\/pharma-stock-to-buy-now-for-an-upside-of-15-are-you-holding-it\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-to-buy-now-for-an-upside-of-15-are-you-holding-it\/#primaryimage","url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg","contentUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg","width":1280,"height":854},{"@type":"BreadcrumbList","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-to-buy-now-for-an-upside-of-15-are-you-holding-it\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/tradebrains.in\/features\/"},{"@type":"ListItem","position":2,"name":"Pharma stock to buy now for an upside of 20%; Are you holding it?"}]},{"@type":"WebSite","@id":"https:\/\/tradebrains.in\/features\/#website","url":"https:\/\/tradebrains.in\/features\/","name":"Trade Brains","description":"Stock Market NSE\/BSE Latest News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tradebrains.in\/features\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666","name":"Trade Brains","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","caption":"Trade Brains"},"sameAs":["http:\/\/tradebrains.in\/"],"url":"https:\/\/tradebrains.in\/features\/author\/trade-brains\/"}]}},"_links":{"self":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/134411","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/comments?post=134411"}],"version-history":[{"count":4,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/134411\/revisions"}],"predecessor-version":[{"id":134424,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/134411\/revisions\/134424"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media\/111747"}],"wp:attachment":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media?parent=134411"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/categories?post=134411"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/tags?post=134411"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}